Wet Age-related Macular Degeneration

Showing 26 - 44 of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Wet Age-related Macular Degeneration Trial in Hungary (ALK4290)

Completed
  • Wet Age-related Macular Degeneration
  • Budapest, Hungary
  • +4 more
Nov 30, 2020

Wet Age-related Macular Degeneration Trial in Hungary (ALK4290)

Completed
  • Wet Age-related Macular Degeneration
  • Budapest, Hungary
  • +4 more
Nov 23, 2020

Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in Virginia Beach (Ziv-Aflibercept 25 MG/ML [Zaltrap],

Completed
  • Wet Macular Degeneration
  • Wet Age-related Macular Degeneration
  • Virginia Beach, Virginia
    Wagner Macula & Retina Center
Oct 5, 2020

Wet Age-related Macular Degeneration Trial (SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Sep 21, 2020

Wet Age-related Macular Degeneration Trial in Beijing (Drug 601)

Unknown status
  • Wet Age-related Macular Degeneration
  • Drug 601
  • Beijing, China
    BeiJing Hospital
Jul 8, 2020

d in"Treat and Extend" Regimen in Treatment-naïve Wet

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Switzerland
    Many Locations
Aug 21, 2019

Wet Age-Related Macular Degeneration Trial in Germany (Ranibizumab 0.5 mg, Aflibercept 2 mg)

Completed
  • Wet Age-Related Macular Degeneration
  • Ranibizumab 0.5 mg
  • Aflibercept 2 mg
  • Koeln, Germany
  • +5 more
Jan 31, 2019

Wet Age-related Macular Degeneration Trial in Shanghai (lucentis, QL1205)

Completed
  • Wet Age-related Macular Degeneration
  • Shanghai, Shanghai, China
    Shanghai General Hospital, Shanghai Jiao Tong University School
Apr 10, 2019

Eylea in Patients With Wet Age-related Macular Degeneration

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Germany
    (unnamed)
Mar 27, 2018

Evaluating Use of Eylea for Treatment of Neovascular Age-related

Terminated
  • Wet Age-related Macular Degeneration
    • Taunton, Somerset, United Kingdom
    • +16 more
    Feb 27, 2017

    Wet Age-related Macular Degeneration Trial in Brazil, Russian Federation (Bevacizumab, Ranibizumab)

    Withdrawn
    • Wet Age-related Macular Degeneration
    • Londrina, Parana, Brazil
    • +12 more
    Mar 30, 2016

    AMD, Wet AMD, Age-Related Macular Degeneration Trial in Worldwide (IRay)

    Completed
    • AMD
    • +6 more
    • IRay
    • Graz, Austria
    • +20 more
    Dec 1, 2014

    Wet Age-Related Macular Degeneration Trial in Czech Republic, France, Switzerland (MP0112)

    Terminated
    • Wet Age-Related Macular Degeneration
    • MP0112
    • Brno, Czech, Czech Republic
    • +7 more
    Apr 14, 2014

    Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration, Macular Degeneration Trial in Mexico Distrito Federal

    Unknown status
    • Age-Related Macular Degeneration
    • +4 more
    • IRay
    • Mexico Distrito Federal, Delegación Coyoacán, Mexico
      Asociación Para Evitar la Ceguera en México, I.A.P.
    Jan 18, 2012

    Wet Age-related Macular Degeneration, Age-related Macular Degeneration, AMD Trial in Milan, London, Manchester (IRay)

    Withdrawn
    • Wet Age-related Macular Degeneration
    • +4 more
    • IRay
    • Milan, Italy
    • +2 more
    Dec 28, 2011

    Wet Age-related Macular Degeneration Trial in Boston, San Antonio (NeoVista Ophthalmic System)

    Completed
    • Wet Age-related Macular Degeneration
    • NeoVista Ophthalmic System
    • Boston, Massachusetts
    • +1 more
    Jul 26, 2011

    Wet Age-Related Macular Degeneration Trial in Australia, United States (PTK787, Placebo)

    Completed
    • Wet Age-Related Macular Degeneration
    • Beverly Hills, California
    • +10 more
    Nov 12, 2008

    Wet Age-Related Macular Degeneration Trial in Switzerland, United Kingdom (ACZ885)

    Completed
    • Wet Age-Related Macular Degeneration
    • Bern, Switzerland
    • +7 more
    Dec 19, 2007